Gene · 200424
Papers2,594
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 2,594
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identifying α-KG-dependent prognostic signature for lower-grade glioma based on transcriptome profiles. | Front Oncol | 2022 | 35965532 | PubTator, text mining | PubMed |
| Chromatin Dynamics in Digestive System Cancer: Commander and Regulator. | Front Oncol | 2022 | 35965507 | PubTator, text mining | PubMed |
| Mutations Affecting Genes in the Proximal T-Cell Receptor Signaling Pathway in Peripheral T-Cell Lymphoma. | Cancers (Basel) | 2022 | 35954378 | PubTator, text mining | PubMed |
| Regulation of the Cancer Stem Phenotype by Long Non-Coding RNAs. | Cells | 2022 | 35954194 | PubTator, text mining | PubMed |
| TET enzymes regulate skeletal development through increasing chromatin accessibility of RUNX2 target genes. | Nat Commun | 2022 | 35953487 | PubTator, text mining | PubMed |
| Raptor downregulation rescues neuronal phenotypes in mouse models of Tuberous Sclerosis Complex. | Nat Commun | 2022 | 35945201 | PubTator, text mining | PubMed |
| MYCN and HIF-1 directly regulate TET1 expression to control 5-hmC gains and enhance neuroblastoma cell migration in hypoxia. | Epigenetics | 2022 | 35942521 | PubTator, text mining | PubMed |
| The Anti-Leukemia Effect of Ascorbic Acid: From the Pro-Oxidant Potential to the Epigenetic Role in Acute Myeloid Leukemia. | Front Cell Dev Biol | 2022 | 35938170 | PubTator, text mining | PubMed |
| Connections between metabolism and epigenetics: mechanisms and novel anti-cancer strategy. | Front Pharmacol | 2022 | 35935878 | PubTator, text mining | PubMed |
| A Novel Anti-Cancer Therapy: CRISPR/Cas9 Gene Editing. | Front Pharmacol | 2022 | 35935840 | PubTator, text mining | PubMed |
| Single cell gene expression profiling of nasal ciliated cells reveals distinctive biological processes related to epigenetic mechanisms in patients with severe COVID-19. | Comput Biol Med | 2022 | 35926268 | PubTator, text mining | PubMed |
| Molecular Features in Lymphatic Metastases Reflect the Metastasis Mechanism of Lymph Nodes With Non-Small-Cell Lung Cancers. | Front Bioeng Biotechnol | 2022 | 35923575 | PubTator, text mining | PubMed |
| Investigation of the target genes of BLV miRNAs and the expression levels of miR-B4-3p and miR-B2-5p in cattle infected with Bovine Leukemia Virus. | Vet Res Forum | 2022 | 35919847 | PubTator, text mining | PubMed |
| Neuroinflammation: Extinguishing a blaze of T cells. | Immunol Rev | 2022 | 35909230 | PubTator, text mining | PubMed |
| Proceedings of the 25th Annual Meeting of the Portuguese Society of Human Genetics (SPGH - Sociedade Portuguesa de Genética Humana). | Medicine (Baltimore) | 2022 | 35905201 | PubTator, text mining | PubMed |
| TET1 regulates gene expression and repression of endogenous retroviruses independent of DNA demethylation. | Nucleic Acids Res | 2022 | 35904814 | PubTator, text mining | PubMed |
| Anticancer Properties of N,N-dibenzylasparagine as an Asparagine (Asp) analog, Using Colon Cancer Caco-2 Cell Line. | Asian Pac J Cancer Prev | 2022 | 35901362 | PubTator, text mining | PubMed |
| Role of Chromatin Modifying Complexes and Therapeutic Opportunities in Bladder Cancer. | Bladder Cancer | 2022 | 35898580 | PubTator, text mining | PubMed |
| Anticancer Effects and Mechanisms of Berberine from Medicinal Herbs: An Update Review. | Molecules | 2022 | 35889396 | PubTator, text mining | PubMed |
| DNA Methylation Episignatures in Neurodevelopmental Disorders Associated with Large Structural Copy Number Variants: Clinical Implications. | Int J Mol Sci | 2022 | 35887210 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/200424/papers?page=33